par Sandberg, J O;Andersson, A.;Eizirik, Decio L. ;Sandler, S
Référence Biochemical and biophysical research communications, 202, 1, page (543-548)
Publication Publié, 1994
Article révisé par les pairs
Titre:
  • Interleukin-1 receptor antagonist prevents low dose streptozotocin induced diabetes in mice.
Auteur:Sandberg, J O; Andersson, A.; Eizirik, Decio L.; Sandler, S
Informations sur la publication:Biochemical and biophysical research communications, 202, 1, page (543-548)
Statut de publication:Publié, 1994
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Animals
Blood Glucose -- metabolism
Cells, Cultured
Diabetes Mellitus, Experimental -- blood
Diabetes Mellitus, Experimental -- pathology
Diabetes Mellitus, Experimental -- prevention & control
Dose-Response Relationship, Drug
Insulin -- secretion
Interleukin 1 Receptor Antagonist Protein
Islets of Langerhans -- drug effects
Islets of Langerhans -- pathology
Islets of Langerhans -- secretion
Male
Mice
Mice, Inbred C57BL
Rats
Rats, Sprague-Dawley
Receptors, Interleukin-1 -- antagonists & inhibitors
Reference Values
Sialoglycoproteins -- pharmacology
Streptozocin -- administration & dosage
Time Factors
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0006-291X
info:doi/10.1006/bbrc.1994.1962
info:pii/S0006-291X(84)71962-0
info:pmid/8037760